Atrial Fibrillation Management by Pulmonary Vein Isolation in Patients With Complex Congenital Heart Disease [0.03%]
复杂先天性心脏病患者的肺静脉隔离法管理房颤
Masayuki Sakai,Satoshi Higuchi,Yuko Matsui et al.
Masayuki Sakai et al.
Precision Medicine for Atrial Fibrillation Recurrence in East Asia: The Genetic and Metabolic Architecture [0.03%]
东亚房颤复发的精准医学：遗传和代谢特征
Takeshi Aiba
Takeshi Aiba
Robert Milford Tungate,Antonio H Frangieh
Robert Milford Tungate
Suitability for Transcarotid Transcatheter Aortic Valve Replacement in the Japanese Population [0.03%]
经颈动脉 transcatheter aortic valve replacement 在日本人群中的适用性
Masaki Nakashima,Natsuko Satomi,Daishi Tazawa et al.
Masaki Nakashima et al.
Background: Transcarotid (TC) transcatheter aortic valve replacement (TAVR) has shown favorable outcomes in selected Western populations; however, data on its suitability in patients undergoing TAVR remain scarce. ...
Min Soo Cho
Min Soo Cho
Medication Adherence and Antithrombotic Therapy Outcomes: Insights From a Post Hoc Analysis of the AFIRE Trial [0.03%]
来自AFIRE试验的事后分析：依从性与抗凝治疗效果的关系研究
Naoki Chiba,Takashi Noda,Kotaro Nochioka et al.
Naoki Chiba et al.
Background: The AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease) trial demonstrated that rivaroxaban monotherapy has noninferior efficacy and superior safety...
Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy [0.03%]
胆固醇-炎症融合假说在动脉粥样硬化中的作用：发病机制和治疗领域的新兴范式
Rui-Xiang Zeng,Sha Li,Jian-Jun Li
Rui-Xiang Zeng
Atherosclerosis (AS) remains the leading cause of cardiovascular morbidity and mortality worldwide despite advances in multidimensional prevention and treatment. We propose a novel cholesterol-inflammation fusion hypothesis, a unifying fram...
Shaun Khanna,Gary C H Gan,Andrew P Sindone et al.
Shaun Khanna et al.
Cardiometabolic disease has become the dominant noncommunicable health challenge of the 21st century, with its burden increasingly centered in Asia. Rising obesity, type 2 diabetes mellitus, hypertension, and dyslipidemia now account for mo...
Sex-Based Differences in Clinical Outcomes With Edoxaban Therapy: A Prespecified Analysis of the EPIC-CAD Trial [0.03%]
艾多沙班治疗的临床结局性别差异：EPIC-CAD试验的事先规定分析
Gi-Hwan Kim,MinSoo Cho,Seonok Kim et al.
Gi-Hwan Kim et al.
Background: Sex-based differences exist in the characteristics and prognosis of patients with atrial fibrillation (AF) and coronary artery disease (CAD). It is still unknown whether optimal antithrombotic therapy differs ...